Abstract
The incidence and spectrum of neoplasms among persons infected with HIV have risen with the increasing survival in the era of combined antiretroviral therapy (cART) and have contributed as a significant cause of death in this population. The specific neoplasms developed include anal cancer, liver cancer, lung cancer, head and neck carcinomas, and carcinomas of the skin, including penile and vulvar/vaginal cancer, among others.
Epidemiologic studies have shown that these neoplasms occur with higher frequency than in non-HIV-infected persons and, in general, tend to occur in patients who are younger than their HIV-negative counterparts. On the other hand, these cancers tend to show atypical pathology (e.g., poorly differentiated neoplasms and high tumor grade) and have a more aggressive behavior (e.g., higher probability of local progression and metastasis), resulting in poorer response to therapy and outcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stebbing J, Duru O, Bower M. Non-AIDS-defining cancers. Curr Opin Infect Dis. 2009;22:7–10.
Pantanowitz L, Dezube BJ. Evolving spectrum and incidence of non-AIDS-defining malignancies. Curr Opin HIV AIDS. 2009;4:27–34.
Ingle SM, May MT, Gill MJ, Mugavero MJ, Lewden C, Abgrall S, et al. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients. Clin Infect Dis. 2014;59:287–97.
Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753–62.
Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, et al. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS. 2012;26:2223–31.
Ribera JM, Morgades M, González-Barca E, Miralles P, López-Guillermo A, Gardella S, et al. Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP. Br J Haematol. 2012;157:637–9.
Xicoy B, Miralles P, Morgades M, Rubio R, Valencia ME, Ribera JM. Long-term follow-up of patients with human immunodeficiency virus infection and advanced stage Hodgkin’s lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine. Haematologica. 2013;98:e85–6.
Mani D, Aboulafia DM. Screening guidelines for non-AIDS defining cancers in HIV-infected individuals. Curr Opin Oncol. 2013;25:518–25.
Vaccher E, Serraino D, Carbone A, De Paoli P. The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care. Oncologist. 2014;19:860–7.
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.
Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, et al. 2006 recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guidelines. J Clin Oncol. 2006;24:3187–205.
Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol. 2010;28:4996–5009.
Rudek MA, Flexner C, Ambinder RF. Use of antineoplastic agents in patients with cancer who have HIV/AIDS. Lancet Oncol. 2011;12:905–12.
Funding
Supported in part by grants from the Red Temática de Investigación Cooperativa en Cáncer (RTICC, FEDER) (RD12/0036/0029); 2014 SGR225 (GRE) Generalitat de Catalunya; PI14/01971 from Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III; and Fundació Internacional Josep Carreras i Obra Social “la Caixa,” Spain.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ribera, JM. (2016). Second Malignancies. In: Hentrich, M., Barta, S. (eds) HIV-associated Hematological Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-319-26857-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-26857-6_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26855-2
Online ISBN: 978-3-319-26857-6
eBook Packages: MedicineMedicine (R0)